{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T01:13:31Z","timestamp":1782695611254,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Pseudohypoparathyroidism type 1B (PHP1B), caused by abnormal methylation of the <jats:italic>GNAS<\/jats:italic> gene leading to parathyroid hormone (PTH) resistance, lacks Albright hereditary osteodystrophy features and is often misdiagnosed. PHP1B and Gitelman syndrome (GS) share overlapping features, including hypokalemia, hypocalcemia, hypomagnesemia, and metabolic alkalosis, posing challenges in clinical differentiation. This study aimed to explore the clinical characteristics, diagnostic strategies, and therapeutic responses of PHP1B presenting with hypokalemia and to explicitly address the diagnostic challenge of differentiating it from GS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective analysis of five patients initially misdiagnosed with GS due to hypokalemia but ultimately confirmed as PHP1B were collected. Whole-exome sequencing (WES) was used to exclude mutations in genes associated with renal tubular diseases, and methylation-sensitive multiplex ligation-dependent probe amplification (MS-MLPA) was employed to assess <jats:italic>GNAS<\/jats:italic> methylation status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients (median age 48 years; 60% female) had prolonged diagnostic delays (median 11 years). Universal clinical manifestations included muscle cramps and weakness. Biochemical profiling revealed hypokalemia (mean potassium 3.14\u00a0mmol\/L), hypocalcemia (mean calcium 1.55\u00a0mmol\/L), and elevated PTH (mean 422.1\u00a0pg\/mL). All patients exhibited intracranial calcifications, predominantly in the basal ganglia. Genetic testing excluded Bartter\/Gitelman syndromes, while MS-MLPA identified multi-differentially methylated region defects (NESP hypermethylation with AS1\/XL\/A\/B hypomethylation) in four patients and isolated A\/B hypomethylation with heterozygous <jats:italic>STX16<\/jats:italic> deletion in case 5. Electrolyte levels improved with calcium, calcitriol, and potassium supplementation, though two patients required long-term potassium maintenance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>PHP1B can present with nonspecific hypokalemia, mimicking GS. Definitive diagnosis requires combined WES and methylation analysis, particularly in WES-negative cases with PTH resistance and intracranial calcifications. Therapeutic focus should prioritize calcium\/calcitriol over potassium supplementation, with epigenetic heterogeneity guiding long-term management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2025.1638472","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:35:27Z","timestamp":1755149727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Pseudohypoparathyroidism type 1B mimicking gitelman syndrome: diagnostic pitfalls and molecular insights"],"prefix":"10.3389","volume":"16","author":[{"given":"Yiming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumayma","family":"Akaaboune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiudan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"91","author":"Blanchard","year":"2017","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.beem.2018.05.006","article-title":"Hypocalcemic disorders","volume":"32","author":"Bove-Fenderson","year":"2018","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13148-025-01865-5","article-title":"DNA methylation in melanoma immunotherapy: mechanisms and therapeutic opportunities","volume":"17","author":"Deshmukh","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1210\/jc.2015-4310","article-title":"The prevalence of GNAS deficiency-related diseases in a large cohort of patients characterized by the EuroPHP network","volume":"101","author":"Elli","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12902-022-01011-9","article-title":"Clinical and genetic analysis of pseudohypoparathyroidism complicated by hypokalemia: a case report and review of the literature","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2423271122","DOI":"10.1073\/pnas.2423271122","article-title":"Bidirectional disruption of GNAS transcripts causes broad methylation defects in pseudohypoparathyroidism type 1B","volume":"122","author":"Iwasaki","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1093\/ejendo\/lvad142","article-title":"Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review","volume":"189","author":"Jiang","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1210\/clinem\/dgab060","article-title":"Molecular definition of pseudohypoparathyroidism variants","volume":"106","author":"J\u00fcppner","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41574-024-01075-8","article-title":"Hypoparathyroidism: diagnosis, management and emerging therapies","volume":"21","author":"Khan","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.endien.2020.09.008","article-title":"Intracranial calcifications in pseudohypoparathyroidism type 1b: report of four cases","volume":"69","author":"Lecumberri","year":"2022","journal-title":"Endocrinol. Diabetes Nutr. Engl. Ed."},{"key":"B11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/jci15219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J. Clin. Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1482728","DOI":"10.3389\/fimmu.2024.1482728","article-title":"Autoimmune disease: a view of epigenetics and therapeutic targeting","volume":"15","author":"Mu","year":"2024","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/eje-20-0625","article-title":"Inactivating PTH\/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients","volume":"184","author":"Pereda","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/humu.21489","article-title":"Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gs\u03b1-receptor interaction","volume":"32","author":"Thiele","year":"2011","journal-title":"Hum. Mutat."},{"key":"B16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/ejendo\/lvad163","article-title":"(Epi)genetic and clinical characteristics in 84 patients with pseudohypoparathyroidism type 1B","volume":"189","author":"Urakawa","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/ndt\/gfac029","article-title":"Parathyroid hormone and phosphate homeostasis in patients with bartter and Gitelman syndrome: an international cross-sectional study","volume":"37","author":"Verploegen","year":"2022","journal-title":"Nephrol. Dial. Transpl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"F543","DOI":"10.1152\/ajprenal.00232.2009","article-title":"A mathematical model of rat ascending henle limb. III. Tubular function","volume":"298","author":"Weinstein","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/a-1528-7471","article-title":"A case of sporadic pseudohypoparathyroidism type 1B presented with hypokalemia","volume":"54","author":"Yang","year":"2022","journal-title":"Horm. Metab. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ando.2022.09.022","article-title":"Sporadic pseudohypoparathyroidism type 1B due to methylation abnormality combined with hypokalemia: a case report and review","volume":"83","author":"Zhang","year":"2022","journal-title":"Ann. Endocrinol. Paris."},{"key":"B21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/nep.14270","article-title":"Interpreting epigenetic causes of recurrent hypokalemia and seizures: gitelman syndrome co-exist with pseudohypoparathyroidism type 1B","volume":"29","author":"Zhang","year":"2024","journal-title":"Nephrol. Carlt."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1638472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:35:28Z","timestamp":1755149728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1638472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":21,"alternative-id":["10.3389\/fgene.2025.1638472"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1638472","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"article-number":"1638472"}}